United States

Omnicell Inc (OMCL.OQ)

OMCL.OQ on NASDAQ Stock Exchange Global Select Market

25 Sep 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and... (more)


Beta: 0.68
Market Cap(Mil.): $1,827.74
Shares Outstanding(Mil.): 37.45
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 192.66 15.77
EPS (TTM): -- -- --
ROI: -- 9.61 15.19
ROE: -- 14.94 13.80

BRIEF-Omnicell Q2 non-gaap earnings per share $0.31

* Omnicell achieves record revenue in the second quarter 2017

Jul 27 2017

BRIEF-Omnicell adds to product offerings in Canada through agreement with McKesson Canada

* Omnicell - agreement with Mckesson Canada under which direct sales of co's former aesynt products will transition from Mckesson Canada back to Omnicell Source text for Eikon: Further company coverage:

May 09 2017

BRIEF-Omnicell announces Q1 GAAP loss per share $0.29

* Q2 earnings per share view $0.31, revenue view $180.8 million -- Thomson Reuters I/B/E/S

May 04 2017

BRIEF-Omnicell Inc announces launch of XT cabinets

* Omnicell announces launch of XT cabinets for acudose-RX customers Source text for Eikon: Further company coverage:

May 01 2017


Earnings vs. Estimates